Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1978 ARTÍCULOS , VIENDO DEL 601 AL 615

GLP-1 and Underlying Beneficial Actions in Alzheimer's Disease, Hypertension, and NASH

Li QX, Gao H, Guo YX, Wang BY, Hua RX, Gao L, Shang HW, Lu X, Xu JD.

Front Endocrinol (Lausanne). 2021 Sep 6;12:721198. doi: 10.3389/fendo.2021.721198. eCollection 2021.

Ferroptosis as a mechanism of neurodegeneration in Alzheimer's disease

Jakaria M, Belaidi AA, Bush AI, Ayton S.

J Neurochem. 2021 Dec;159(5):804-825. doi: 10.1111/jnc.15519. Epub 2021 Oct 9.

Visual short-term memory impairments in presymptomatic familial Alzheimer's disease: A longitudinal observational study

Pavisic IM, Nicholas JM, Pertzov Y, O'Connor A, Liang Y, Collins JD, Lu K, Weston PSJ, Ryan NS, Husain M, Fox NC, Crutch SJ.

Neuropsychologia. 2021 Nov 12;162:108028. doi: 10.1016/j.neuropsychologia.2021.108028. Epub 2021 Sep 22.

Alzheimer's disease neuropathology is exacerbated following traumatic brain injury. Neuroprotection by co-administration of nanowired mesenchymal stem cells and cerebrolysin with monoclonal antibodies to amyloid beta peptide

Sharma HS, Muresanu DF, Castellani RJ, Nozari A, Lafuente JV, Buzoianu AD, Sahib S, Tian ZR, Bryukhovetskiy I, Manzhulo I, Menon PK, Patnaik R, Wiklund L, Sharma A.

Prog Brain Res. 2021;265:1-97. doi: 10.1016/bs.pbr.2021.04.008. Epub 2021 Aug 12.

Deciphering the focal role of endostatin in Alzheimer's disease

Kaur D, Behl T, Chigurupati S, Sehgal A, Singh S, Sharma N, Badavath VN, Vargas-De-La-Cruz C, Bhatia S, Al-Harrasi A, Dey A, Aleya L, Bungau S.

Environ Sci Pollut Res Int. 2021 Nov;28(44):61998-62011. doi: 10.1007/s11356-021-16567-7. Epub 2021 Sep 25.

Impact of Pharmacotherapy on Insomnia in Patients with Alzheimer's Disease

Roland JP, Bliwise DL.

Drugs Aging. 2021 Nov;38(11):951-966. doi: 10.1007/s40266-021-00891-1. Epub 2021 Sep 27.

A Review of APOE Genotype-Dependent Autophagic Flux Regulation in Alzheimer's Disease

Chen H, Chen F, Zhang M, Chen Y, Cui L, Liang C.

J Alzheimers Dis. 2021;84(2):535-555. doi: 10.3233/JAD-210602.

Bile Acids as Key Modulators of the Brain-Gut-Microbiota Axis in Alzheimer's Disease

Mulak A.

J Alzheimers Dis. 2021;84(2):461-477. doi: 10.3233/JAD-210608.

The NLRP3 Inflammasome in the Pathogenesis and Treatment of Alzheimer's Disease

Golzari-Sorkheh M, Brown CE, Weaver DF, Reed MA.

J Alzheimers Dis. 2021;84(2):579-598. doi: 10.3233/JAD-210660.

Flavonoids with Potential Anti-Amyloidogenic Effects as Therapeutic Drugs for Treating Alzheimer's Disease

Wang Q, Dong X, Zhang R, Zhao C.

J Alzheimers Dis. 2021;84(2):505-533. doi: 10.3233/JAD-210735.

Genetic Therapies for Alzheimer's Disease: A Scoping Review

Lennon MJ, Rigney G, Raymont V, Sachdev P.

J Alzheimers Dis. 2021;84(2):491-504. doi: 10.3233/JAD-215145.

Effect of Levetiracetam on Cognition in Patients With Alzheimer Disease With and Without Epileptiform Activity: A Randomized Clinical Trial

Vossel K, Ranasinghe KG, Beagle AJ, La A, Ah Pook K, Castro M, Mizuiri D, Honma SM, Venkateswaran N, Koestler M, Zhang W, Mucke L, Howell MJ, Possin KL, Kramer JH, Boxer AL, Miller BL, Nagarajan SS, Kirsch HE.

JAMA Neurol. 2021 Nov 1;78(11):1345-1354. doi: 10.1001/jamaneurol.2021.3310.

Effect of Methylphenidate on Apathy in Patients With Alzheimer Disease: The ADMET 2 Randomized Clinical Trial

Mintzer J, Lanctôt KL, Scherer RW, Rosenberg PB, Herrmann N, van Dyck CH, Padala PR, Brawman-Mintzer O, Porsteinsson AP, Lerner AJ, Craft S, Levey AI, Burke W, Perin J, Shade D; ADMET 2 Research Group.

JAMA Neurol. 2021 Nov 1;78(11):1324-1332. doi: 10.1001/jamaneurol.2021.3356.

The Many Faces of Post-Ischemic Tau Protein in Brain Neurodegeneration of the Alzheimer's Disease Type

Pluta R, Czuczwar SJ, Januszewski S, Jabłoński M.

Cells. 2021 Aug 27;10(9):2213. doi: 10.3390/cells10092213.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias